vs

Side-by-side financial comparison of Energy Vault Holdings, Inc. (NRGV) and RHYTHM PHARMACEUTICALS, INC. (RYTM). Click either name above to swap in a different company.

RHYTHM PHARMACEUTICALS, INC. is the larger business by last-quarter revenue ($60.1M vs $21.9M, roughly 2.7× Energy Vault Holdings, Inc.). RHYTHM PHARMACEUTICALS, INC. runs the higher net margin — -92.6% vs -148.5%, a 55.9% gap on every dollar of revenue. On growth, Energy Vault Holdings, Inc. posted the faster year-over-year revenue change (156.4% vs 83.8%). Over the past eight quarters, Energy Vault Holdings, Inc.'s revenue compounded faster (67.9% CAGR vs 43.8%).

Energy Vault is a global energy storage company specializing in gravity and kinetic energy based, long-duration energy storage products. Energy Vault's primary product is a gravity battery to store energy by stacking heavy blocks made of composite material into a structure, capturing potential energy in the elevation gain of the blocks. When demand for electricity is high, these blocks are lowered with the motors functioning as generators and delivering electricity to the grid.

Rhythm Pharmaceuticals is a biopharmaceutical firm focused on developing and commercializing targeted therapies for rare genetic disorders causing severe unmanageable obesity, including POMC deficiency, LEPR deficiency, and Bardet-Biedl syndrome. It serves patients in North America and Europe who lack effective standard treatments for their chronic life-altering conditions.

NRGV vs RYTM — Head-to-Head

Bigger by revenue
RYTM
RYTM
2.7× larger
RYTM
$60.1M
$21.9M
NRGV
Growing faster (revenue YoY)
NRGV
NRGV
+72.6% gap
NRGV
156.4%
83.8%
RYTM
Higher net margin
RYTM
RYTM
55.9% more per $
RYTM
-92.6%
-148.5%
NRGV
Faster 2-yr revenue CAGR
NRGV
NRGV
Annualised
NRGV
67.9%
43.8%
RYTM

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
NRGV
NRGV
RYTM
RYTM
Revenue
$21.9M
$60.1M
Net Profit
$-32.5M
$-55.6M
Gross Margin
21.9%
88.1%
Operating Margin
-32.5%
-87.1%
Net Margin
-148.5%
-92.6%
Revenue YoY
156.4%
83.8%
Net Profit YoY
-53.7%
EPS (diluted)
$-0.20
$-0.83

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
NRGV
NRGV
RYTM
RYTM
Q1 26
$21.9M
$60.1M
Q4 25
$57.3M
Q3 25
$33.3M
$51.3M
Q2 25
$8.5M
$48.5M
Q1 25
$8.5M
$32.7M
Q4 24
$33.5M
$41.8M
Q3 24
$1.2M
$33.3M
Q2 24
$3.8M
$29.1M
Net Profit
NRGV
NRGV
RYTM
RYTM
Q1 26
$-32.5M
$-55.6M
Q4 25
$-47.5M
Q3 25
$-26.8M
$-52.9M
Q2 25
$-34.9M
$-46.6M
Q1 25
$-21.1M
$-49.5M
Q4 24
$-61.8M
$-43.3M
Q3 24
$-26.6M
$-43.6M
Q2 24
$-26.2M
$-32.3M
Gross Margin
NRGV
NRGV
RYTM
RYTM
Q1 26
21.9%
88.1%
Q4 25
91.6%
Q3 25
27.0%
89.3%
Q2 25
29.6%
88.6%
Q1 25
57.1%
88.8%
Q4 24
7.7%
90.9%
Q3 24
40.3%
88.5%
Q2 24
27.8%
89.9%
Operating Margin
NRGV
NRGV
RYTM
RYTM
Q1 26
-32.5%
-87.1%
Q4 25
-82.2%
Q3 25
-52.8%
-102.6%
Q2 25
-330.7%
-93.4%
Q1 25
-244.8%
-143.7%
Q4 24
-150.6%
-98.6%
Q3 24
-2258.1%
-132.0%
Q2 24
-739.7%
-139.2%
Net Margin
NRGV
NRGV
RYTM
RYTM
Q1 26
-148.5%
-92.6%
Q4 25
-83.0%
Q3 25
-80.5%
-103.1%
Q2 25
-410.3%
-96.1%
Q1 25
-247.7%
-151.4%
Q4 24
-184.7%
-103.6%
Q3 24
-2217.9%
-131.2%
Q2 24
-694.6%
-110.9%
EPS (diluted)
NRGV
NRGV
RYTM
RYTM
Q1 26
$-0.20
$-0.83
Q4 25
$-0.73
Q3 25
$-0.16
$-0.82
Q2 25
$-0.22
$-0.75
Q1 25
$-0.14
$-0.81
Q4 24
$-0.41
$-0.71
Q3 24
$-0.18
$-0.73
Q2 24
$-0.18
$-0.55

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
NRGV
NRGV
RYTM
RYTM
Cash + ST InvestmentsLiquidity on hand
$55.2M
$340.6M
Total DebtLower is stronger
$160.6M
Stockholders' EquityBook value
$30.5M
$122.9M
Total Assets
$298.0M
$442.3M
Debt / EquityLower = less leverage
5.27×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
NRGV
NRGV
RYTM
RYTM
Q1 26
$55.2M
$340.6M
Q4 25
$388.9M
Q3 25
$32.7M
$416.1M
Q2 25
$22.3M
$291.0M
Q1 25
$21.2M
$314.5M
Q4 24
$30.0M
$320.6M
Q3 24
$51.1M
$298.4M
Q2 24
$106.8M
$319.1M
Total Debt
NRGV
NRGV
RYTM
RYTM
Q1 26
$160.6M
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
NRGV
NRGV
RYTM
RYTM
Q1 26
$30.5M
$122.9M
Q4 25
$139.1M
Q3 25
$80.5M
$148.8M
Q2 25
$90.3M
$-11.9M
Q1 25
$114.9M
$18.9M
Q4 24
$126.3M
$21.7M
Q3 24
$179.1M
$11.2M
Q2 24
$195.6M
$39.3M
Total Assets
NRGV
NRGV
RYTM
RYTM
Q1 26
$298.0M
$442.3M
Q4 25
$480.2M
Q3 25
$281.9M
$506.9M
Q2 25
$248.8M
$372.7M
Q1 25
$217.4M
$386.7M
Q4 24
$183.9M
$392.3M
Q3 24
$252.9M
$363.6M
Q2 24
$255.6M
$381.8M
Debt / Equity
NRGV
NRGV
RYTM
RYTM
Q1 26
5.27×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
NRGV
NRGV
RYTM
RYTM
Operating Cash FlowLast quarter
$-53.8M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
NRGV
NRGV
RYTM
RYTM
Q1 26
$-53.8M
Q4 25
$-25.4M
Q3 25
$-11.7M
$-26.6M
Q2 25
$15.4M
$-23.3M
Q1 25
$-2.7M
$-40.4M
Q4 24
$-34.8M
$-18.8M
Q3 24
$-9.2M
$-25.2M
Q2 24
$-12.8M
$-29.1M
Free Cash Flow
NRGV
NRGV
RYTM
RYTM
Q1 26
Q4 25
Q3 25
$-27.2M
Q2 25
$6.9M
Q1 25
$-9.5M
Q4 24
$-45.4M
Q3 24
$-36.4M
Q2 24
$-25.1M
FCF Margin
NRGV
NRGV
RYTM
RYTM
Q1 26
Q4 25
Q3 25
-81.5%
Q2 25
81.6%
Q1 25
-111.5%
Q4 24
-135.5%
Q3 24
-3039.9%
Q2 24
-665.1%
Capex Intensity
NRGV
NRGV
RYTM
RYTM
Q1 26
Q4 25
Q3 25
46.4%
Q2 25
98.8%
Q1 25
79.5%
Q4 24
31.5%
Q3 24
2273.1%
Q2 24
325.8%

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons